U.S. Agent
U.S. Agent Service – Cosmetics
The “Modernization of Cosmetics Regulation Act 2022” (“MoCRA”) was published in December 2022 and introduces extensive amendments to the U.S. Federal Food, Drug, and Cosmetic Act (“FD&C Act”).
MoCRA brings new legal requirements and significantly reshapes the regulatory landscape for cosmetics in the United States.
As your FDA Representative (“U.S. Agent”), MDSS assists your company in the safe and compliant marketing of your cosmetic products in the U.S.
The deadline for product listing and facility registration under MoCRA was December 29, 2023.
Our comprehensive support
- Facility registration
- Product listing
- Review of relevant documentation and product labeling to ensure compliance with current U.S. regulations
- Product safety substantiation
- Acting as the primary point of contact for the responsible U.S. authority (FDA)
- Management of adverse events
- Updates on key regulatory changes
- Consulting on specific regulations in individual U.S. states
*With respect to new legal requirements under “MoCRA”
Need a Quote for Cosmetic Testing?
Every cosmetic product is different. Let us know what you are developing and which tests you are considering, and we will help you identify the appropriate next steps.
Submit your request to receive a quotation for your selected cosmetic testing services.
Not sure which test you need? You can describe your product and objectives in the form, and we will help clarify your enquiry.
Laboratory testing is provided through our laboratory partner. Test availability, scope, timelines and fees are subject to confirmation. Testing does not replace the manufacturer's applicable safety assessment, Product Information File (PIF), Cosmetic Product Safety Report (CPSR), notification or other regulatory obligations.
